TrialsAlert vs Antidote
Research monitoring vs trial enrollment
By Victor Lafforgue, Founder of TrialsAlert. Last updated March 2026. TrialsAlert is our product.
What is Antidote?
Antidote (antidote.me) is a clinical trial matching service that connects patients with trials they may be eligible to join. Patients enter their condition and health profile, and Antidote's matching engine suggests specific trials recruiting in their area. The service is free for patients — Antidote's revenue comes from pharmaceutical sponsors who pay for recruitment services. Antidote's focus is on trial enrollment: helping patients find trials they can participate in today.
How is TrialsAlert different from Antidote?
The key difference is purpose. Antidote helps you find a trial to join right now. TrialsAlert helps you stay informed about all the research happening for your condition over time. Antidote answers the question "Which trials can I enroll in?" TrialsAlert answers the question "What is new in clinical research for my condition this week?" These are complementary goals. A patient might use Antidote to find a trial to join, and TrialsAlert to track the broader landscape of research activity — including trials they cannot join but that may lead to new treatments in the future.
Trial matching vs condition monitoring
Trial matching services like Antidote evaluate your specific health profile against the eligibility criteria of recruiting trials. This is valuable if you are actively seeking enrollment. Condition monitoring, which TrialsAlert provides, tracks all trials related to your condition — recruiting or not, eligible or not — and classifies them by potential impact. This gives you a broader view of the research landscape, including early-phase studies that may represent future treatment options.